AMAzeem Tariq Malik

Azeem Tariq Malik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Azeem Tariq Malik has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prognostic value of tip-to-apex distance in prophylactic fixation for pathological peritrochanteric femur fractures

    by Logan M. Good, David P. Pettit, Azeem T. Malik, Carl D. Quinion, Brandon W. Jonard, Thomas J. Scharschmidt

  • Medical Malpractice Litigation in Spine Surgery

    by Muhammad Talal Ibrahim, Umm E. Salma Shabbar Banatwala, Graham Albert, Azeem Tariq Malik, Elizabeth Yu, Venkat Kavuri, Varun Kumar Singh

    Background: Spine surgery is a high-risk specialty for litigation, with most practicing surgeons encountering at least 1 malpractice claim during their careers. This systematic review aimed to evaluate the trends and characteristics of medical malpractice claims after spine surgery. Methods: A systematic search was conducted on PubMed, Scopus, Embase, and Web of Science to find studies reporting on patients who underwent spine surgery and sued their surgeons. Studies that included original extractable data on litigation after spine surgery were included without date or geographical restrictions. Outcome measures included demographic details, anatomic regions, diagnosis, procedure, verdict, defendant's specialty, reason for litigation, patient injuries or damages, and payouts. Two reviewers independently screened and selected the articles. The protocol was prospectively registered on PROSPERO. Results: This review reports on 5,514 malpractice cases in 54 studies covering 1968 to 2023. Most of the literature has been published in the United States (28/54 studies). The numbers of males (n = 1,192, 50.6%) and females (n = 1,166, 49.4%) were almost equal. Most patients had undergone lumbar spine surgery (53.9%), followed by cervical (26.6%) spine surgery. Most surgeries were performed electively (70.9%), with a minority (29.1%) being emergent surgeries. The top 3 common alleged reasons for litigation were (1) delay or failure to diagnose or treat (1,380 cases), (2) intraoperative/procedural error (901 cases), and (3) inadequate informed consent (694 cases). The top 3 common injuries reported were (1) new neurological deficit, that is, nerve or spinal cord injury (1,423 cases); (2) persistent pain or suffering (585 cases); and (3) additional surgery required (381 cases). Most cases concluded with either a defense verdict (56.8%) or settlement (11.1%), with only 29.3% resulting in a plaintiff verdict. Orthopaedic surgeons represented 47.1% of the providers sued, whereas 35.9% were neurosurgeons. Payouts resulting from plaintiff verdicts were significantly higher than payouts in settlement (mean difference = $1,304,100, 95% confidence interval $93,430-$2,514,780, p = 0.01). Conclusion: The most common reason for litigation after spine surgery is a new neurological deficit, mainly resulting from a delay in diagnosis or treatment, intraoperative error, or inadequate informed consent. Emphasizing communication and informed consent is an effective method of improving patient care and decreasing litigation. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.


  • Declining Trend in Anti-osteoporotic Treatment, Despite a Rise in DEXA Screening Following “Sentinel” Distal Radius Fractures

    by Azeem Tariq Malik, Adam Gordon, Hisham Awan, Safdar N. Khan, Kanu S. Goyal

    Purpose: To understand national trends and costs associated with the utilization of anti-osteoporotic medication and DEXA screening within the year following a sentinel/primary distal radius fracture. Methods: The 2008-2015Q1 Humana Administrative Claims database was queried to identify patients aged ≥50 years, with a “sentinel” occurrence of a primary closed distal radius fracture. Linear regression models were used to report and assess for significant trends in utilization of anti-osteoporotic medication and DEXA screenings within the year following the fracture. Multivariate logistic regression analyses were used to assess for factors associated with receiving or not receiving anti-osteoporotic medication. Results: A total of 14 526 sentinel distal radius fractures were included in the study. Only 7.2% (n = 1046) of patients received anti-osteoporosis medication in the year following the distal radius fracture. Treatment with medication for osteoporosis declined from 8.2% in 2008 to 5.9% in 2015, whereas the rate of DEXA screening increased from 14.8% in 2008 to 23.6% in 2015. The most common prescribed treatment was alendronate sodium (n = 835; 79.8%—$49/patient). Factors associated with increased odds of receiving anti-osteoporotic medication were age 70 to 79 years (odds ratio [OR], 1.45; P = .014), age 80 to 89 years (OR, 1.66; P = .001), Asian (OR, 2.95; P = .002) or Hispanic (OR, 1.77; P = .006) ethnicity, belonging to South (OR, 1.19; P = .029) or West (OR, 1.37; P = .010), and having an Elixhauser Comorbidity Index score of 3 (OR, 2.14; P = .024) or > 3 (OR, 2.05; P = .022). Conclusions: Despite a rising utilization of DEXA screening following “sentinel” distal radius fractures, the proportion of individuals who receive anti-osteoporotic treatment is decreasing over time.


  • Increasing Frailty in Geriatric Emergency General Surgery: A Cause for Concern

    by Dahlia M. Kenawy, Savannah M. Renshaw, Emily George, Azeem Tariq Malik, Courtney E. Collins


  • Total elbow arthroplasty cases involving orthopaedic residents do not affect short-term postoperative complications

    by Adam M Gordon, Azeem Tariq Malik

    Impact of resident participation on short-term postoperative outcomes after total elbow arthroplasty has not been studied. The aim was to investigate whether resident participation affects postoperative complication rates, operative time, and length of stay. The American College of Surgeons National Surgical Quality Improvement Program registry was queried from 2006 to 2012 for patients undergoing total elbow arthroplasty. A 1:1 propensity score match was performed to match resident cases to attending-only cases. Comorbidities, surgical time, and short-term (30-day) postoperative complications were compared between groups. Multivariate Poisson regression was used to compare the rates of postoperative adverse events between groups. After propensity score match, 124 cases (50% with resident participation) were included. Adverse event rate after surgery was 18.5%. On multivariate analysis, there were no significant differences between attending-only cases and resident involved cases, with regards to short-term major complications, minor complications, or any complications (all p > 0.071). Total operative time was similar between cohorts (149.16 vs. 165.66 min; p = 0.157). No difference was observed in the length of hospital stay (2.95 vs. 2.6 days), p = 0.399. Resident participation during total elbow arthroplasty is not associated with increased risk for short-term medical or surgical postoperative complications or operative efficiency.


  • What Is the Value of Undergoing Surgery for Spinal Metastases at Dedicated Cancer Centers?

    by Azeem Tariq Malik, Safdar N. Khan, Ryan T. Voskuil, John H. Alexander, Joseph P. Drain, Thomas J. Scharschmidt

    Background: The Alliance of Dedicated Cancer Centers is an organization of 11 leading cancer institutions and affiliated hospitals that are exempt from the Medicare prospective system hospital reimbursement policies. Because of their focus on cancer care and participation in innovative cancer treatment methods and protocols, these hospitals are reimbursed based on their actual billings. The perceived lack of incentive to meet a predetermined target price and reduce costs has spurred criticism of the value of cancer care at these institutions. The rationale of our study was to better understand whether dedicated cancer centers (DCCs) deliver high-value care for patients undergoing surgical treatment of spinal metastases. Question/purpose: Is there a difference in 90-day complications and reimbursements between patients undergoing surgical treatment (decompression or fusion) for spinal metastases at DCCs and those treated at nonDCC hospitals? Methods: The 2005 to 2014 100% Medicare Standard Analytical Files database was queried using ICD-9 procedure and diagnosis codes to identify patients undergoing decompression (03.0, 03.09, and 03.4) and/or fusion (81.0X) for spinal metastases (198.5). The database does not allow us to exclude the possibility that some patients were treated with fusion for stabilization of the spine without decompression, although this is likely an uncommon event. Patients undergoing vertebroplasty or kyphoplasty for metastatic disease were excluded. The Medicare hospital provider identification numbers were used to identify the 11 DCCs. The study cohort was categorized into two groups: DCCs and nonDCCs. Although spinal metastases are known to occur among nonMedicare and younger patients, the payment policies of these DCCs are only applicable to Medicare beneficiaries. Therefore, to keep the study objective relevant to current policy and value-based discussions, we performed the analysis using the Medicare dataset. After applying the inclusion and exclusion criteria, we included 17,776 patients in the study, 6% (1138 of 17,776) of whom underwent surgery at one of the 11 DCCs. Compared with the nonDCC group, DCC group hospitals operated on a younger patient population and on more patients with primary renal cancers. In addition, DCCs were more likely to be high-volume facilities with National Cancer Institute designations and have a voluntary or government ownership model. Patients undergoing surgery for spinal metastases at DCCs were more likely to have spinal decompression with fusion than those at nonDCCs (40% versus 22%; p < 0.001) and had a greater length and extent of fusion (at least four levels of fusion; 34% versus 29%; p = 0.001). Patients at DCCs were also more likely than those at nonDCCs to receive postoperative adjunct treatments such as radiation (16% versus 13.5%; p = 0.008) and chemotherapy (17% versus 9%; p < 0.001), although this difference is small and we do not know if this meets a minimum clinically important difference. To account for differences in patients presenting at both types of facilities, multivariate logistic regression mixed-model analyses were used to compare rates of 90-day complications and 90-day mortality between DCC and nonDCC hospitals. Controls were implemented for baseline clinical characteristics, procedural factors, and hospital-level factors (such as random effects). Generalized linear regression mixed-modeling was used to evaluate differences in total 90-day reimbursements between DCCs and nonDCCs. Results: After adjusting for differences in baseline demographics, procedural factors, and hospital-level factors, patients undergoing surgery at DCCs had lower odds of experiencing sepsis (6.5% versus 10%; odds ratio 0.54 [95% confidence interval 0.40 to 0.74]; p < 0.001), urinary tract infections (19% versus 28%; OR 0.61 [95% CI 0.50 to 0.74]; p < 0.001), renal complications (9% versus 13%; OR 0.55 [95% CI 0.42 to 0.72]; p < 0.001), emergency department visits (27% versus 31%; OR 0.78 [95% CI 0.64 to 0.93]; p = 0.01), and mortality (39% versus 49%; OR 0.75 [95% CI 0.62 to 0.89]; p = 0.001) within 90 days of the procedure compared with patients treated at nonDCCs. Undergoing surgery at a DCC (90-day reimbursement of USD 54,588 ± USD 42,914) compared with nonDCCs (90-day reimbursement of USD 49,454 ± USD 38,174) was also associated with reduced 90-day risk-adjusted reimbursements (USD -14,802 [standard error 1362] ; p < 0.001). Conclusion: Based on our findings, it appears that DCCs offer high-value care, as evidenced by lower complication rates and reduced reimbursements after surgery for spinal metastases. A better understanding of the processes of care adopted at these institutions is needed so that additional cancer centers may also be able to deliver similar care for patients with metastatic spine disease. Level of Evidence: Level III, therapeutic study.


  • Open Access

    Cost Analysis of Medical Students Applying to Orthopaedic Surgery Residency: Implications for the 2020 to 2021 Application Cycle During COVID-19

    by Adam M. Gordon, Azeem Tariq Malik, Thomas J. Scharschmidt, Kanu S. Goyal

    Introduction: Although studies have evaluated the economic burden to medical students desiring an orthopaedic residency broadly, no study has evaluated in detail the application costs, away rotation costs, interview costs, and total costs. Given that the Association of American Medical Colleges and the American Orthopaedic Association's Council of Orthopaedic Residency Directors have recommended orthopaedic surgery residency programs for the 2021 residency application cycle cancel away rotations and in-person interviews, our objective was to evaluate the cost savings to medical students applying during this time and the potential implications. Methods: Using the 2019 to 2020 Texas STAR Dashboard database, we queried responses from applicants applying to orthopaedic surgery residency. The dashboard was queried to record the application costs, away rotation costs, interview costs, and total costs for medical school seniors applying to orthopaedic surgery residency. Demographic information for applicants was also recorded. Mean and median costs were reported with percentile distributions and geographic comparisons. A Kruskal-Wallis H test was used to determine whether there were statistically significant differences in mean costs by medical school region. Results: The 2019 to 2020 Texas STAR Dashboard database had 473 responses from applicants to orthopaedic surgery residency. The mean application costs were $1,990, away rotation costs were $3,182, interview costs were $3,129, and total costs were $8,205. The mean total costs for applicants from Midwest schools were significantly less than Western schools ($7,410/applicant vs. $9,909/applicant) (p = 0.008). There was no significant difference between the mean application fees between regions. Away rotation costs for applicants from schools in the Midwest ($2,413/applicant) were significantly less compared with Northeast ($3,279/applicant), South ($3,343/applicant), and West ($3,913/applicant) (all p < 0.002). Interview costs for applicants from schools in the Northeast ($2,891/applicant) were less than applicants from Western US schools ($3,831/applicant) (p = 0.038). Conclusion: In the COVID-19 era, orthopaedic residency applicants could save on average $6,311 through the use of virtual interviews and lack of away rotations. There are geographic implications, with applicants from Western US medical schools potentially saving most.


  • The Association of “U.S. News & World Report” Hospital Rankings and Outcomes Following Anterior Cervical Fusions

    by Azeem Tariq Mbbs Malik, Jack J. Xie, Joseph P. Drain, Elizabeth Yu, Safdar N. Khan, Jeffery Kim

    Study Design.: Retrospective observational study. Objective.: The aim of this study was to evaluate whether there are any differences in outcomes and costs for elective one- to three-level anterior cervical fusions (ACFs) performed at US News and World Report (USNWR) ranked and unranked hospitals. Summary of Background Data.: Although the USNWR rankings are advertised by media and are routinely used by patients as a guide in seeking care, evidence regarding whether these rankings are reflective of actual clinical outcome remains limited. Methods.: The 2010–2014 USNWR hospital rankings were used to identify ranked hospitals in “Neurosurgery” and “Orthopedics.” The 2010–2014 100% Medicare Standard Analytical Files (SAF100) were used to identify patients undergoing elective ACFs at ranked and unranked hospitals. Multivariable logistic regression and generalized linear regression analyses were used to assess for differences in 90-day outcomes and costs between ranked and unranked hospitals. Results.: A total of 110,520 patients undergoing elective one- to three-level ACFs were included in the study, of which 10,289 (9.3%) underwent surgery in one of the 100 ranked hospitals. Following multivariate analysis, there were no significant differences between ranked versus unranked hospitals with regards to wound complications (1.2% vs. 1.1%; P = 0.907), cardiac complications (12.9% vs. 11.9%; P = 0.055), pulmonary complications (3.7% vs. 6.7%; P = 0.654), urinary tract infections (7.3% vs. 5.8%; P = 0.120), sepsis (9.3% vs. 7.9%; P = 0.847), deep venous thrombosis (1.9% vs. 1.3%; P = 0.077), revision surgery (0.3% vs. 0.3%; P = 0.617), and all-cause readmissions (4.7% vs. 4.4%; P = 0.266). Ranked hospitals, as compared to unranked hospitals, had a slightly lower odds of experiencing renal complications (7.0% vs. 4.9%; P = 0.047), but had significantly higher risk-adjusted 90-day charges (+$17,053; P < 0.001) and costs (+ $1695; P < 0.001). Conclusion.: Despite the higher charges and costs of care at ranked hospitals, these facilities appear to have similar outcomes as compared to unranked hospitals following elective ACFs. Level of Evidence: 3


  • Hospital network participation and outcomes following elective posterior lumbar fusions – are mergers effective?

    by Azeem Tariq Malik, Elizabeth Yu, Joseph P. Drain, Jeffery Kim, Safdar N. Khan